OPCH
Option Care Health, Inc.
OPCH's fundamentals are mixed: free cash flow grew 28%, while its operating margin held steady at 5.9%. At 23x earnings, it's trading below its usual 26x. Analysts expect earnings growth.
OPCH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
OPCH's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
OPCH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $31.68 | — |
| Cheap | 20x | $27.79 | -12% |
| Current | 23x | $31.68 | — |
| Fair | 26x | $36.15 | +14% |
| Expensive | 38x | $52.50 | +66% |
Historical ranges are pointers, not guarantees.
OPCH's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
OPCH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OPCH, with profitability holding steady.
OPCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.02 | +47% |
| Q3 2026 | $1.38 | +8.7% |
| Q2 2026 | $1.32 | +4.8% |
| Q1 2026 | $1.28 | +2.4% |
| Q4 2025 | $1.27 | +3.3% |
| Q3 2025 | $1.27 | +5.8% |
| Q2 2025 | $1.26 | +5% |
| Q1 2025 | $1.25 | -18% |
| Q4 2024 | $1.23 | -17% |
OPCH earned $1.38 per share over the past year, up 8.7% from the year before.
OPCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +4.1% |
| Q2 2026 | $1.4B | +1.9% |
| Q1 2026 | $1.4B | +1.3% |
| Q4 2025 | $1.5B | +16% |
| Q3 2025 | $1.4B | +12% |
| Q2 2025 | $1.4B | +15% |
| Q1 2025 | $1.3B | +16% |
| Q4 2024 | $1.3B | +12% |
OPCH's revenue has grown year over year every quarter since late 2020: $1.5B last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6% | +0.1 points |
| Q2 2026 | 5.9% | +0.1 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 6.2% | -0.7 points |
| Q3 2025 | 5.9% | -0.8 points |
| Q2 2025 | 5.8% | -0.7 points |
| Q1 2025 | 5.9% | -0.1 points |
| Q4 2024 | 6.9% | -0.6 points |
OPCH's operating margin was 6% last quarter, about level with the same quarter a year ago.
OPCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $108M | -17% |
| Q2 2026 | $172.5M | +112% |
| Q1 2026 | -$21.2M | -$4.6M |
| Q4 2025 | $22.2M | -14% |
| Q3 2025 | $130.2M | -14% |
| Q2 2025 | $81.2M | -56% |
| Q1 2025 | -$16.6M | +$58M |
| Q4 2024 | $25.8M | -17% |
OPCH generated $282M in free cash flow over the past year, up 28% from the year before.
OPCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -3M shares |
| 1 year | -7.7% | -12.6M shares |
| 3 years | -17% | -30M shares |
| 5 years | -17% | -30.9M shares |
| Available history | -3.7% | -5.8M shares |
OPCH has 150M diluted shares, down 7.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $95.1M |
| Q3 2025 | $62.5M |
| Q4 2024 | $92.6M |
| Q3 2024 | $42M |
| Q2 2024 | $78.1M |
| Q1 2024 | $40.1M |
| Q4 2023 | $75.2M |
OPCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.4x | Moderate |
| Q4 2024 | 1.8x | Healthy |
OPCH's net debt is about 2.1 years of its operating earnings (EBITDA), about the same as a year ago.
OPCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.8 | Neutral |
| Stochastic | 98.1 | Overbought |
OPCH's weekly RSI is 70 (neutral) and its Stochastic is 98 (overbought).
OPCH PE vs Healthcare Sector
| Metric | OPCH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 32 | 29 | 3 pts above |
OPCH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
OPCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.3 | 8.2% above |
| 20 week MA | $25.6 | 24% above |
| 50 week MA | $27.3 | 16% above |
| 100 week MA | $28.6 | 11% above |
| 200 week MA | $29.5 | 7.2% above |
OPCH has climbed back above all five of its weekly moving averages, and it's now 7.2% above its 200-week average.
OPCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $15.6 | +5.1% |
| 2021 | $15.6 | $28.0 | +80% |
| 2022 | $28.0 | $30.2 | +8.1% |
| 2023 | $30.2 | $33.7 | +11% |
| 2024 | $33.7 | $22.9 | -32% |
| 2025 | $22.9 | $32.6 | +43% |
| 2026 YTD | $32.6 | $31.7 | -2.8% |
OPCH has finished higher in five of the last six years. It's down 2.8% so far in 2026.